2024-01-01 2024-12-31 false Capium Accounts Production 1.1 12378007 2024-01-01 2024-12-31 12378007 bus:AbridgedAccounts 2024-01-01 2024-12-31 12378007 bus:FRS102 2024-01-01 2024-12-31 12378007 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12378007 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12378007 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12378007 2024-01-01 2024-12-31 12378007 2024-12-31 12378007 bus:RegisteredOffice 2024-01-01 2024-12-31 12378007 core:WithinOneYear 2024-12-31 12378007 core:AfterOneYear 2024-12-31 12378007 1 2024-01-01 2024-12-31 12378007 bus:Director1 2024-01-01 2024-12-31 12378007 bus:Director1 2024-12-31 12378007 bus:Director1 2023-01-01 2023-12-31 12378007 2023-01-01 12378007 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 12378007 2023-01-01 2023-12-31 12378007 2023-12-31 12378007 core:WithinOneYear 2023-12-31 12378007 core:AfterOneYear 2023-12-31 12378007 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 12378007 core:MotorCars 2024-01-01 2024-12-31 12378007 core:MotorCars 2024-12-31 12378007 core:MotorCars 2023-12-31 12378007 core:ComputerEquipment 2024-01-01 2024-12-31 12378007 core:ComputerEquipment 2024-12-31 12378007 core:ComputerEquipment 2023-12-31 12378007 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 12378007 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 12378007 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 12378007 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 12378007 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 12378007 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 12378007 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 12378007 core:Non-currentFinancialInstruments 2024-12-31 12378007 core:Non-currentFinancialInstruments 2023-12-31 12378007 core:ShareCapital 2024-12-31 12378007 core:ShareCapital 2023-12-31 12378007 core:RetainedEarningsAccumulatedLosses 2024-12-31 12378007 core:RetainedEarningsAccumulatedLosses 2023-12-31 12378007 dpl:Item1 2024-01-01 12378007 dpl:Item1 2024-12-31 12378007 dpl:Item1 2023-01-01 12378007 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12378007
England & Northern Ireland

 

 

 

GANEF PHARMA LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

GANEF PHARMA LIMITED
Contents Page
For the year ended 31 December 2024
Accountants report
You consider that the company is exempt from an audit for the year ended 31 December 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
STAR BUSINESS SERVICES LIMITED
31 December 2024



....................................................

STAR BUSINESS SERVICES LIMITED
2 WINCHESTER CLOSE
STEVENAGE
SG1 4NZ
28 September 2025
1
 
 		 Notes
 		 2024
£		   2023
£
Fixed assets      
Tangible fixed assets 3 7,057    8,607 
Investments 4 15,442    15,442 
22,499    24,049 
Current assets      
Debtors 0    7,831 
Cash at bank and in hand 17,263    1,563 
17,263    9,394 
Creditors: amount falling due within one year (21,069)   (15,753)
Net current assets (3,806)   (6,359)
 
Total assets less current liabilities 18,693    17,690 
Net assets 18,693    17,690 
 

Capital and reserves 		     
Called up share capital 100    100 
Profit and loss account 18,593    17,590 
Shareholders' funds 18,693    17,690 
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 28 September 2025 and were signed by:


-------------------------------
Ali Nuhu
Director
2
General Information
GANEF PHARMA LIMITED is a private company, limited by shares, registered in England & Northern Ireland, registration number 12378007, registration address 19 ALDERMAN AVENUE, BARKING ENGLAND, IG11 0LX.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 3 (2023 : 2).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Computer Equipment   Total
  £   £   £
At 01 January 2024 15,000    5,000    20,000 
Additions -    -    - 
Disposals -    -    - 
At 31 December 2024 15,000    5,000    20,000 
Depreciation
At 01 January 2024 8,545    2,848    11,393 
Charge for year 1,162    388    1,550 
On disposals -    -    - 
At 31 December 2024 9,707    3,236    12,943 
Net book values
Closing balance as at 31 December 2024 5,293    1,764    7,057 
Opening balance as at 01 January 2024 6,455    2,152    8,607 


4.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 January 2024 15,442    15,442 
Additions -    - 
Disposals -    - 
At 31 December 2024 15,442    15,442 

3